Drug interactions
Bumetanide + Empagliflozin-linagliptin
Severity: Moderate
Bumetanide and Empagliflozin-linagliptin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Empagliflozin promotes osmotic diuresis and bumetanide is a potent loop diuretic, so combined use raises the risk of dehydration, hypotension, electrolyte disturbance and acute kidney injury.
What this interaction means in plain words
Bumetanide and Empagliflozin-linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Bumetanide belongs to Cardiovascular; Empagliflozin-linagliptin belongs to Endocrine.
Why it happens
Additive diuretic and natriuretic effects.
What to do
Monitor volume status, blood pressure, electrolytes and renal function, particularly at initiation. Consider lowering the loop diuretic dose if volume depletion develops.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bumetanide and Empagliflozin-linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Empagliflozin-linagliptin
Other interactions of Bumetanide
Frequently asked questions
Can I take Bumetanide with Empagliflozin-linagliptin?
MediHelp rates the interaction as moderate. Bumetanide and Empagliflozin-linagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Empagliflozin promotes osmotic diuresis and bumetanide is a potent loop diuretic, so combined use raises the risk of dehydration, hypotension, electrolyte disturbance and acute kidney injury.
How serious is the interaction between Bumetanide and Empagliflozin-linagliptin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor volume status, blood pressure, electrolytes and renal function, particularly at initiation. Consider lowering the loop diuretic dose if volume depletion develops.
What other medicines interact with Empagliflozin-linagliptin?
MediHelp also lists interactions of Empagliflozin-linagliptin with, for example, Fosphenytoin, Rifampin, Rifapentine. The full list is on the Empagliflozin-linagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
